Three-year Outcomes After Conversion From Monthly to Every 2-month Belatacept Maintenance Therapy in Kidney Transplant Recipients: Results From a Randomized Controlled Trial.

Johnson, Aileen C; Karadkhele, Geeta M; Shenvi, Neeta; Easley, Kirk A; Larsen, Christian P; Badell, I Raul

Johnson, Aileen C; Karadkhele, Geeta M; Shenvi, Neeta; Easley, Kirk A; Larsen, Christian P; Badell, I Raul.

Afiliación

Johnson AC; Emory Transplant Center, Atlanta, GA.
Karadkhele GM; Emory Transplant Center, Atlanta, GA.
Shenvi N; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA.
Easley KA; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA.
Larsen CP; Emory Transplant Center, Atlanta, GA.
Badell IR; Emory Transplant Center, Atlanta, GA.

Transplant Direct ; 9(3): e1449, 2023 Mar.

Article en En | MEDLINE | ID: mdl-36875938

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Transplant Direct Año: 2023 Tipo del documento: Article País de afiliación: Gabón Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google